300 results on '"Forman, S."'
Search Results
2. LB1702 Lebrikizumab does not impact vaccine-induced immune responses: Results from a phase 3 study in adult patients with moderate-to-severe atopic dermatitis
3. 5607610 HETEROGENEITY IN COGNITIVE PRESENTATIONS AMONG CHILDREN AND ADOLESCENTS WITH SICKLE CELL DISEASE
4. P1296: SUPPRESSING SYNTHESIS OF THE LONG ISOFORM OF THE PROLACTIN RECEPTOR IS A TARGETED STRATEGY TO TREAT AUTOIMMUNE B-LYMPHOPROLIFERATIVE DISEASES AND B CELL MALIGNANCIES
5. PO-1171 Ten-year follow-up of tandem autologous transplantation with total marrow irradiation for myeloma
6. Audit of waist measurement methods during statutory diving medical assessments
7. 208 Long-Term Safety and Disease Control With Ruxolitinib Cream in Atopic Dermatitis: Results From Two Phase 3 Studies
8. Volcanic origin for Younger Dryas geochemical anomalies ca. 12,900 cal B.P.
9. Factors Associated With Large Improvements in Health-Related Quality of Life in Patients With Atrial Fibrillation
10. Allogeneic Bone Marrow Transplantation for BCR-ABL Positive Acute Lymphoblastic Leukemia
11. Myeloablative Regimens Containing High Dose Etoposide Followed by Allogeneic or Autologous Bone Marrow Transplantation for Hematologic Malignancies
12. ASN002 demonstrates efficacy and improves inflammation in AD
13. ASN002 证明有疗效并可改善AD 炎症
14. MDS AS A CAUSE FOR PROLONGED HEMATOLOGIC TOXICITY AFTER TREATMENT WITH CD19 TARGETED CAR-T CELL THERAPY IN PATIENTS WITH RELAPSED REFRACTORY LYMPHOMA
15. PET‐ADAPTED NIVOLUMAB +/‐ ICE AS INITIAL SALVAGE THERAPY IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA
16. The oral Janus kinase/spleen tyrosine kinase inhibitorASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate‐to‐severe atopic dermatitis: results from a randomized double‐blind placebo‐controlled study
17. Bone Marrow Transplantation from Histocompatible Sibling Donors for Patients with Acute Lymphoblastic Leukemia
18. Lung, Renal, Thyroid and Cataract Toxicities after Myeloablative Total Marrow Irradiation (TMI) in Patients Undergoing Hematopoietic Cell Transplantation (HCT)
19. 554 The Janus kinase 1 (JAK1) inhibitor PF-04965842 reduces signs and symptoms of moderate to severe atopic dermatitis (AD)
20. Phase I/II trial of the oral regimen ixazomib, pomalidomide, and dexamethasone in relapsed/refractory multiple myeloma
21. Therapy-Related Myelodysplasia: Somatic Mutations and Allogeneic Hematopoietic Cell Transplantation Outcomes
22. National Low-Level Waste Management Program final summary report of key activities and accomplishments for fiscal year 1995
23. Redirecting T cells to eradicate B-cell acute lymphoblastic leukemia: bispecific T-cell engagers and chimeric antigen receptors
24. The Lathrop Wells volcanic center: Status of field and geochronology studies
25. P252 Accurate measurement of lung function in the workplace and potential effects of underestimation
26. ZUMA-2: A phase 2 multi-center study evaluating the efficacy of KTE-C19 (Anti-CD19 CAR T cells) in patients with relapsed/refractory Mantle cell lymphoma (R/R MCL)
27. A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation
28. Évaluation de la stratégie posologique optimale à moyen terme pour l’utilisation de l’adalimumab dans l’hidrosadénite suppurée modérée à sévère ; résultats intégrés des études de phase 3, randomisées, contrôlées contre placebo PIONEER I & II
29. Paralimbic and lateral prefrontal encoding of reward value during intertemporal choice in attempted suicide
30. Development and application of spherically curved charge-coupled device imagers
31. Therapy-related ALL: cytogenetic features and hematopoietic cell transplantation outcome
32. A phase II study of vorinostat and rituximab for treatment of newly diagnosed and relapsed/refractory indolent non-Hodgkin lymphoma
33. Last interglacial vegetation and climate history from the Portuguese coast
34. Secondary Prevention of Myocardial Infarction with Antiplatelet Drugs
35. Bone Marrow Transplantation for Acute Leukemia
36. Changes in Renal Blood Flow, Glomerular Filtration, and Vasoactive Hormones in Bone-Marrow-Transplant Recipients After Total-Body Irradiation
37. THE ROLE OF THE DIGITAL COMPUTER IN AERONAUTICAL RESEARCH AND DEVELOPMENT
38. Investigating work-related neoplasia associated with solar radiation
39. Mycophenolate mofetil-based salvage as acute GVHD prophylaxis after early discontinuation of tacrolimus and/or sirolimus
40. IT-03 * ADOPTIVE TRANSFER OF IL13R 2-SPECIFIC T CELLS FOR THE TREATMENT OF GLIOBLASTOMA: BUILDING ON CLINICAL ACHIEVEMENTS WITH SECOND-GENERATION CARs
41. ME-01 * GLIOMA CELL ADHESION AND INVASION REGULATED BY PROINFLAMMATORY CYTOKINE IN A NOVEL SURFACE/MATRIX CULTURE SYSTEM
42. BI-31 * ANALYSIS AND QUANTIFICATION OF MULTIPLE ANTIGEN EXPRESSION IN GLIOBLASTOMA
43. Sclerodermatous chronic GVHD in patients receiving tyrosine kinase inhibitors after allogeneic hematopoietic cell transplantation
44. Real-time assessment of relapse risk based on the WT1 marker in acute leukemia and myelodysplastic syndrome patients after hematopoietic cell transplantation
45. Phase 1 Dose Escalation Trial of Total Marrow and Lymphoid Irradiation (TMLI) Using Helical Tomotherapy Combined With Etoposide (VP16) and Cyclophosphamide (CY) in Patients With Refractory Acute Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation (alloHCT)
46. Etomidate produces similar allosteric modulation in α1β3δ and α1β3γ2L GABAAreceptors
47. IMMUNOLOGY RESEARCH
48. Efficient selection of genetically modified human T cells using methotrexate-resistant human dihydrofolate reductase
49. Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological malignancies
50. Extramedullary (EM) Relapse Following Total Marrow and Lymphoid Irradiation (TMLI) in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (HCT)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.